共 396 条
[1]
John L(2015)The rapid emergence of novel therapeutics in advanced malignant melanoma Dermatol Ther (Heidelb) 5 151-169
[2]
Cowey CL(2004)Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels Control Clin Trials 25 535-552
[3]
Wilke RJ(2009)Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency Eur J Cancer 45 347-353
[4]
Burke LB(2006)Improvements in measuring the health-related quality of life of cancer patients Expert Rev Pharmacoecon Outcomes Res 6 97-105
[5]
Erickson P(2006)Using patient-reported outcomes in clinical oncology practice: benefits, challenges and next steps Expert Rev Pharmacoecon Outcomes Res 6 87-95
[6]
Bottomley A(1993)The European Organisation for Research and Treatment of Cancer QLQ- 8 C20: a quality of life instrument for use in international clinical trials of oncology J Natl Cancer Inst 85 365-376
[7]
Jones D(1993)The Functional Assessment of Cancer Therapy scale: development and validation of the general measure J Clin Oncol 11 570-579
[8]
Claassens L(2012)Assessing the social impact of cancer: a review of available tools Support Care Cancer 20 2249-2257
[9]
Smith AB(2005)Development and validation of a psychosocial screening instrument for cancer Health Qual Life Outcomes 7 54-386
[10]
Wright EP(2005)Development and evaluation of an instrument to assess social difficulties in routine oncology practice Qual Life Res 14 373-911